NeoGenomics wraps up takeover of liquid biopsy platform company Inivata
NeoGenomics, a US-based cancer diagnostics and pharma services company, has wrapped up its previously announced $390 million takeover of Inivata, a liquid biopsy platform company ... Read More
GE Healthcare unveils Serena Bright mammography solution for biopsy
GE Healthcare has unveiled new Serena Bright, a contrast-enhanced mammography solution for biopsy, which is claimed to help clinicians to detect breast cancer patients in ... Read More